Global Bioenergies (Alternext Paris : ALGBE) announces having delivered isobutene produced at its industrial pilot to ARLANXEO, a world leader in high‐quality synthetic rubbers headquartered in the Netherlands.
TEXCELL of France and ATRI (Agricultural Technology Research Institute) in Taiwan announce a strategic partnership aimed at offering viral safety service solutions to biotech and pharmaceutical companies operating in the Far East.
On 2 May 2016 TEXCELL of France signed a contract for the acquisition of Germany’s Vivo Science GmbH, a GLP/GMP-compliant laboratory specialized in toxicology, immunology and virology in vivo studies. Texcell, supplier of services in viral security and immunology, is buying Vivo Science, a German company that provides services to the pharmaceutical industry (CRO) and has specialized over the last 15 years in immunogenicity, immunotoxicology and virology in vivo assays. The acquisition is (...)
Pharnext, an advanced clinical stage biopharmaceutical company specialized in neurodegenerative diseases, announces the nomination of a new Board of Directors chaired by Michel de Rosen. Michel de Rosen – Chairman of Pharnext’s Board of Directors. President of Eutelsat Communications and member of ABB and Faurecia’s Boards of Directors. Michel de Rosen brings over 20 years of experience in the biotech and pharmaceutical (...)
The Investissements d’Avenir programme provides €9 million funding to Global Bioenergies and IBN-One, as part of a programme involving Cristal Union and L’Oréal. They announce the launch of a 44-month industrial and commercial project focused on the first bio-isobutene plant.
Global Bioenergies (Alternext Paris : ALGBE) announces having delivered isobutene produced at its industrial pilot to Clariant, a leading specialty chemical company.
The French program for international startups with Genopole. After a successful first edition, the French Tech Ticket program is back for season 2, with more incubators all over France ready to welcome the most talented entrepreneurs, and even more startup-tailored benefits including a € 45,000 prize money for the winners ! While 23 startup projects out of more than 700 applications were awarded a French Tech Ticket last year, 70 projects will be selected to join one of the 41 partner (...)
Acticor Biotech, biotechnology company which is developing an anti-thrombotic agent without bleeding risk for the emergency treatment of ischemic strokes, has just completed a €1.4 million capital increase. The funds were raised from investors via the Anaxago crowdfunding platform (€740,000), from research association ARMESA (€500,000) and from business angels (€170,000).
UM Cure 2020 is a new European Consortium to foster research on metastatic uveal melanoma and identify new treatments for this serious disease. Under the coordination of Institut Curie in Paris, PEP-Therapy and 11 other partners have received 6 million euros of funding from the European Union’s Horizon 2020 research and innovation programme to identify new therapeutic approaches to treat metastatic uveal melanoma in a 5-year (...)
ANKENY, Iowa – September 5, 2016 – Advanced Analytical Technologies, Inc., (AATI) establishes a French office at Genopole Biocluster near Paris France to expand direct sales, distribution and service into France, the French speaking part of Belgium and Luxembourg. The Fragment AnalyzerTM Automated CE System has become a laboratory standard for the automated analysis of nucleic acids since its release in 2012. Now just four years later, we are excited to announce the opening of our French (...)